The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemical Drug and Biologic Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemical Drug
1.2.3 Biologic Drug
1.3 Market by Application
1.3.1 Global Chemical Drug and Biologic Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemical Drug and Biologic Drug Market Perspective (2018-2029)
2.2 Chemical Drug and Biologic Drug Growth Trends by Region
2.2.1 Global Chemical Drug and Biologic Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chemical Drug and Biologic Drug Historic Market Size by Region (2018-2023)
2.2.3 Chemical Drug and Biologic Drug Forecasted Market Size by Region (2024-2029)
2.3 Chemical Drug and Biologic Drug Market Dynamics
2.3.1 Chemical Drug and Biologic Drug Industry Trends
2.3.2 Chemical Drug and Biologic Drug Market Drivers
2.3.3 Chemical Drug and Biologic Drug Market Challenges
2.3.4 Chemical Drug and Biologic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical Drug and Biologic Drug Players by Revenue
3.1.1 Global Top Chemical Drug and Biologic Drug Players by Revenue (2018-2023)
3.1.2 Global Chemical Drug and Biologic Drug Revenue Market Share by Players (2018-2023)
3.2 Global Chemical Drug and Biologic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemical Drug and Biologic Drug Revenue
3.4 Global Chemical Drug and Biologic Drug Market Concentration Ratio
3.4.1 Global Chemical Drug and Biologic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical Drug and Biologic Drug Revenue in 2022
3.5 Chemical Drug and Biologic Drug Key Players Head office and Area Served
3.6 Key Players Chemical Drug and Biologic Drug Product Solution and Service
3.7 Date of Enter into Chemical Drug and Biologic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical Drug and Biologic Drug Breakdown Data by Type
4.1 Global Chemical Drug and Biologic Drug Historic Market Size by Type (2018-2023)
4.2 Global Chemical Drug and Biologic Drug Forecasted Market Size by Type (2024-2029)
5 Chemical Drug and Biologic Drug Breakdown Data by Application
5.1 Global Chemical Drug and Biologic Drug Historic Market Size by Application (2018-2023)
5.2 Global Chemical Drug and Biologic Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chemical Drug and Biologic Drug Market Size (2018-2029)
6.2 North America Chemical Drug and Biologic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chemical Drug and Biologic Drug Market Size by Country (2018-2023)
6.4 North America Chemical Drug and Biologic Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemical Drug and Biologic Drug Market Size (2018-2029)
7.2 Europe Chemical Drug and Biologic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chemical Drug and Biologic Drug Market Size by Country (2018-2023)
7.4 Europe Chemical Drug and Biologic Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemical Drug and Biologic Drug Market Size (2018-2029)
8.2 Asia-Pacific Chemical Drug and Biologic Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chemical Drug and Biologic Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Chemical Drug and Biologic Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemical Drug and Biologic Drug Market Size (2018-2029)
9.2 Latin America Chemical Drug and Biologic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chemical Drug and Biologic Drug Market Size by Country (2018-2023)
9.4 Latin America Chemical Drug and Biologic Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical Drug and Biologic Drug Market Size (2018-2029)
10.2 Middle East & Africa Chemical Drug and Biologic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Chemical Drug and Biologic Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Chemical Drug and Biologic Drug Introduction
11.1.4 Johnson & Johnson Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Chemical Drug and Biologic Drug Introduction
11.2.4 Novartis Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Chemical Drug and Biologic Drug Introduction
11.3.4 Roche Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Chemical Drug and Biologic Drug Introduction
11.4.4 AbbVie Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Chemical Drug and Biologic Drug Introduction
11.5.4 Merck & Co. Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Chemical Drug and Biologic Drug Introduction
11.6.4 Bristol Myers Squibb Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Chemical Drug and Biologic Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Chemical Drug and Biologic Drug Introduction
11.8.4 Pfizer Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Chemical Drug and Biologic Drug Introduction
11.9.4 Sanofi Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Chemical Drug and Biologic Drug Introduction
11.10.4 Takeda Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Chemical Drug and Biologic Drug Introduction
11.11.4 AstraZeneca Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Chemical Drug and Biologic Drug Introduction
11.12.4 Bayer Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Detail
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Chemical Drug and Biologic Drug Introduction
11.13.4 Eli Lilly & Co. Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Chemical Drug and Biologic Drug Introduction
11.14.4 Gilead Sciences Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Chemical Drug and Biologic Drug Introduction
11.15.4 Amgen Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Chemical Drug and Biologic Drug Introduction
11.16.4 Novo Nordisk Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Detail
11.17.2 Teva Business Overview
11.17.3 Teva Chemical Drug and Biologic Drug Introduction
11.17.4 Teva Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Detail
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Chemical Drug and Biologic Drug Introduction
11.18.4 Boehringer Ingelheim Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.18.5 Boehringer Ingelheim Recent Development
11.19 Biogen
11.19.1 Biogen Company Detail
11.19.2 Biogen Business Overview
11.19.3 Biogen Chemical Drug and Biologic Drug Introduction
11.19.4 Biogen Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.19.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Detail
11.20.2 Astellas Business Overview
11.20.3 Astellas Chemical Drug and Biologic Drug Introduction
11.20.4 Astellas Revenue in Chemical Drug and Biologic Drug Business (2018-2023)
11.20.5 Astellas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details